Interethnic variation in lipid profiles: implications for underidentification of African–Americans at risk for metabolic disorders

References

• Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ. Cardiovasc. Qual. Outcomes 3(2), 181–187 (2010).
   Google Scholar
• Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among U.S. adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann. Epidemiol. 18(4), 302–309 (2008).
   PubMed Web of Science ®Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care 29(6), 1263–1268 (2006).
   PubMed Web of Science ®Google Scholar
• Chang M-H, Ned REM, Hong Y et al. Racial/ethnic variation in the association of lipid-related genetic variants with blood lipids in the US adult population / clinical perspective. Circulation: Cardiovascular Genetics 4(5), 523–533 (2011).
   PubMed Web of Science ®Google Scholar
• Dai S, Fulton JE, Harrist RB, Grunbaum JA, Steffen LM, Labarthe DR. Blood lipids in children: age-related patterns and association with body-fat indices: Project HeartBeat! Am. J. Prev. Med. 37(Suppl. 1), S56–S64 (2009).
   PubMed Web of Science ®Google Scholar
• Lamb MM, Ogden CL, Carroll MD, Lacher DA, Flegal KM. Association of body fat percentage with lipid concentrations in children and adolescents: United States, 1999–2004. Am. J. Clin. Nutr. 94(3), 877–883 (2011).
   PubMed Web of Science ®Google Scholar
• CDC. Prevalence of abnormal lipid levels among youths – United States, 1999–2006. Morb. Mort. Wkly Rep. 2010(59), 29–33 (2010).
   Google Scholar
• D’Adamo E, Northrup V, Weiss R et al. Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion. Am. J. Clin. Nutr. 92(3), 500–508 (2010).
   PubMed Web of Science ®Google Scholar
• Giannini C, Santoro N, Caprio S et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 34(8), 1869–1874 (2011).
   PubMed Web of Science ®Google Scholar
• Miljkovic-Gacic I, Bunker CH, Ferrell RE et al. Lipoprotein subclass and particle size differences in Afro–Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation. Metab. Clin. Exp. 55(1), 96–102 (2006).
   PubMedGoogle Scholar
• Johnson JL, Slentz CA, Duscha BD et al. Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis 176(2), 371–377 (2004).
   PubMedGoogle Scholar
• Adeyemo A, Gerry N, Chen G et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 5(7), e1000564 (2009).
   PubMed Web of Science ®Google Scholar
• Rotimi CN, Dunston GM, Berg K et al. In search of susceptibility genes for Type 2 diabetes in West Africa: the design and results of the first phase of the AADM study. Ann. Epidemiol. 11(1), 51–58 (2001).
   Google Scholar
• CDC. National health and nutrition examination protocol. National Health and Nutrition Examination Protocol (2003–2004).
   Google Scholar
• CDC. National health and nutrition examination protocol. National Health and Nutrition Examination Protocol (2007–2008).
   Google Scholar
• Kant AK, Graubard BI. Race-ethnic, family income, and education differentials in nutritional and lipid biomarkers in US children and adolescents: NHANES 2003–2006. Am. J. Clin. Nutr. 96(3), 601–612 (2012).
   PubMed Web of Science ®Google Scholar
• Walker SE, Gurka MJ, Oliver MN, Johns DW, DeBoer MD. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr. Metab. Cardiovasc. Dis. 22(2), 141–148 (2012).
   PubMed Web of Science ®Google Scholar
• Raffensperger S, Kuczmarski MF, Hotchkiss L, Cotugna N, Evans MK, Zonderman AB. Effect of race and predictors of socioeconomic status on diet quality in the HANDLS Study sample. J. Natl Med. Assoc. 102(10), 923–930 (2010).
   PubMedGoogle Scholar
• Deshmukh-Taskar PR, O’Neil CE, Nicklas TA et al. Dietary patterns associated with metabolic syndrome, sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr. 12(12), 2493–2503 (2009).
   PubMed Web of Science ®Google Scholar
• Clarke PJ, O’Malley PM, Johnston LD, Schulenberg JE, Lantz P. Differential trends in weight-related health behaviors among American young adults by gender, race/ethnicity, and socioeconomic status: 1984–2006. Am. J. Public Health 99(10), 1893–1901 (2009).
   Google Scholar
• Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J. Am. Diet. Assoc. 108(2), 276–286; discussion 286 (2008).
   PubMedGoogle Scholar
• Luke A, Dugas L, Durazo-Arvizu R, Cao G, Cooper R. Assessing physical activity and its relationship to cardiovascular risk factors: NHANES 2003–2006. BMC Public Health 11(1), 387 (2011).
   Google Scholar
• Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med. Sci. Sports Exerc. 40(1), 181–188 (2008).
   PubMed Web of Science ®Google Scholar
• Furtado JD, Campos H, Sumner AE, Appel LJ, Carey VJ, Sacks FM. Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial. Am. J. Clin. Nutr. 92(4), 714–722 (2010).
   Google Scholar
• Howard BV, Curb JD, Eaton CB et al. Low-fat dietary pattern and lipoprotein risk factors: the Women’s Health Initiative Dietary Modification Trial. Am. J. Clin. Nutr. 91(4), 860–874 (2010).
   PubMed Web of Science ®Google Scholar
• Monda KL, Ballantyne CM, North KE. Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study. J. Lipid Res. 50(8), 1685–1691 (2009).
   PubMed Web of Science ®Google Scholar
• Hosain GM, Rahman M, Williams KJ, Berenson AB. Racial differences in the association between body fat distribution and lipid profiles among reproductive-age women. Diabetes Metab. 36(4), 278–285 (2010).
   Google Scholar
• Després JP, Couillard C, Gagnon J et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 20(8), 1932–1938 (2000).
   PubMed Web of Science ®Google Scholar
• Raman A, Sharma S, Fitch MD, Fleming SE. Anthropometric correlates of lipoprotein profile and blood pressure in high BMI African American children. Acta Paediatr. 99(6), 912–919 (2010).
   Google Scholar
• Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metab. Clin. Exp. 54(7), 902–909 (2005).
   Google Scholar
• Chow CC, Periwal V, Csako G et al. Higher acute insulin response to glucose may determine greater free fatty acid clearance in African–American women. J. Clin. Endocrinol. Metab. 96(8), 2456–2463 (2011).
   Google Scholar
• Hasson RE, Adam TC, Davis JN et al. Ethnic differences in insulin action in obese African–American and Latino adolescents. J. Clin. Endocrinol. Metab. 95(8), 4048–4051 (2010).
   PubMed Web of Science ®Google Scholar
• Gower BA, Herd SL, Goran MI. Anti-lipolytic effects of insulin in African American and white prepubertal boys. Obes. Res. 9(3), 224–228 (2001).
   Google Scholar
• Deo RC, Reich D, Tandon A et al. Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study. PLoS Genet. 5(1), e1000342 (2009).
   Google Scholar
• Romeo S, Yin W, Kozlitina J et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 119(1), 70–79 (2009).
   PubMed Web of Science ®Google Scholar
• Romeo S, Pennacchio LA, Fu Y et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39(4), 513–516 (2007).
   PubMed Web of Science ®Google Scholar
• Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc. Med. 18(1), 6–14 (2008).
   PubMed Web of Science ®Google Scholar
• Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010).
   PubMed Web of Science ®Google Scholar
• Adeyemo A, Bentley A, Meilleur K et al. . Transferability and fine mapping of genome-wide associated loci for lipids in African Americans. BMC Med. Genet. 13(1), 88 (2012).
   Google Scholar
• Chang MH, Yesupriya A, Ned RM, Mueller PW, Dowling NF. Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey. BMC Med. Genet. 11, 62 (2010).
   PubMedGoogle Scholar
• Adeyemo A, Rotimi C. Genetic variants associated with complex human diseases show wide variation across multiple populations. Public Health Genomics 13(2), 72–79 (2010).
   PubMed Web of Science ®Google Scholar
• Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329(5993), 841–845 (2010).
   PubMed Web of Science ®Google Scholar
• Freedman BI, Langefeld CD, Murea M et al. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol. Dial. Transplant. 26(11), 3805–3810 (2011).
   Google Scholar
• Bentley AR, Doumatey AP, Chen G et al. Variation in APOL1 contributes to ancestry-level differences in HDLcHDL-kidney function association. Int. J. Nephrol. 2012(11), 10 (2012).
   Google Scholar
• Love-Gregory L, Sherva R, Sun L et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum. Mol. Genet. 17(11), 1695–1704 (2008).
   PubMed Web of Science ®Google Scholar
• Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354(12), 1264–1272 (2006).
   PubMed Web of Science ®Google Scholar
• Mbikay M, Mayne J, Seidah NG, Chrétien M. Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms. Med. Hypotheses 69(5), 1010–1017 (2007).
   PubMedGoogle Scholar
• Simon JA, Lin F, Hulley SB et al. Phenotypic predictors of response to simvastatin therapy among African–Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am. J. Cardiol. 97(6), 843–850 (2006).
   PubMed Web of Science ®Google Scholar
• Goldberg RB, Guyton JR, Mazzone T et al. Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with Type 2 diabetes and hypercholesterolemia. Diabetes Care 33(5), 1021–1024 (2010).
   Google Scholar
• Mangravite LM, Medina MW, Cui J et al. Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin. Arterioscler. Thromb. Vasc. Biol. 30(7), 1485–1492 (2010).
   PubMed Web of Science ®Google Scholar
• Ho RH, Choi L, Lee W et al. Effect of drug transporter genotypes on pravastatin disposition in European– and African–American participants. Pharmacogenet. Genomics 17(8), 647–656 (2007).
   PubMed Web of Science ®Google Scholar
• Margolis KL, Dunn K, Simpson LM et al.; ALLHAT Collaborative Research Group. Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the Antihypertensive and Lipid Lowering to Prevent Heart Attack Trial (ALLHAT-LLT). Am. Heart J. 158(6), 948–955 (2009).
   Google Scholar
• Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am. J. Med. 119(10), 812–819 (2006).
   PubMed Web of Science ®Google Scholar
• Sumner AE. Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J. Pediatr. 155(3), S7.e7–S7.11 (2009).
   Google Scholar
• Gaillard T. Insulin resistance and cardiovascular disease risk in black people of the African Diaspora. Curr. Cardiovasc. Risk Rep. 4(3), 186–194 (2010).
   Google Scholar
• Dagogo-Jack I, Dagogo-Jack S. Dissociation between cardiovascular risk markers and clinical outcomes in African Americans: need for greater mechanistic insight. Curr. Cardiovasc. Risk Rep. 5(3), 200–206 (2011).
   Google Scholar
• Osei K. Metabolic syndrome in blacks: are the criteria right? Curr. Diab. Rep. 10(3), 199–208 (2010).
   PubMed Web of Science ®Google Scholar
• Gower BA, Ard JD, Hunter GR, Fernandez J, Ovalle F. Elements of the metabolic syndrome: association with insulin sensitivity and effects of ethnicity. Metab. Syndr. Relat. Disord. 5(1), 77–86 (2007).
   Google Scholar
• Goedecke JH, Utzschneider K, Faulenbach MV et al. Ethnic differences in serum lipoproteins and their determinants in South African women. Metab. Clin. Exp. 59(9), 1341–1350 (2010).
   PubMed Web of Science ®Google Scholar
• Li C, Ford ES, Meng YX, Mokdad AH, Reaven GM. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc. Diabetol. 7, 4 (2008).
   PubMed Web of Science ®Google Scholar
• Stein E, Kushner H, Gidding S, Falkner B. Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metab. Clin. Exp. 56(7), 954–960 (2007).
   Google Scholar
• Gaillard T, Schuster D, Osei K. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome. Metab. Clin. Exp. 59(8), 1115–1123 (2010).
   Google Scholar
• Erqou S, Kaptoge S, Perry PL et al.; Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302(4), 412–423 (2009).
   PubMed Web of Science ®Google Scholar
• Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301(22), 2331–2339 (2009).
   PubMed Web of Science ®Google Scholar
• Virani SS, Brautbar A, Davis BC et al. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 125(2), 241–249 (2012).
   PubMed Web of Science ®Google Scholar
• Ridker PM. Lipoprotein(a), ethnicity, and cardiovascular risk: erasing a paradox and filling a clinical gap. Circulation 125(2), 207–209 (2012).
   Google Scholar
• Sharma S, Merchant J, Fleming SE. Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD. Cardiovasc. Diabetol. 11, 10 (2012).
   Google Scholar